ST. LOUIS, Feb. 22, 2024 Stifel Financial Corp. today reported selected operating results for January 31, 2024 in an effort to provide timely information to investors on certain key performance.
A controversial Alzheimer's drug that was trumpeted as the first to ever treat the cognitive decline associated with the devastating brain disorder has been pulled from the market, its maker Biogen announced Wednesday. It showed a reduction in cognitive decline in one of the studies, but not the other.